Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Galderma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

(-) Cancellation by sponsor (48)
ARTG (52)
Australian public assessment report (AusPar) (6)
Prescription medicine registration (2)
Prescription medicine decision summary (1)

Date

2025 (1)
2024 (1)
2023 (2)
2021 (7)
2020 (3)
2019 (13)
2018 (5)
2017 (16)

Search

Filters applied:

Cancellation by sponsor

Clear all

Sponsor content

48 result(s) found, displaying 1 to 10

NEMLUVIO nemolizumab 30mg powder and solution for injection pre filled syringe Cancelled under Section 30(1)(a) of the Act

11 August 2025

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Applicator, <specify> Cancelled under Section 41GL(d) of the Act

28 June 2024

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Cannula, tissue injection Cancelled under Section 41GL(d) of the Act

28 June 2023

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane Lyps Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic Cancelled under Section 41GL(d) of the Act

28 June 2023

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
METROGEL metronidazole 7.5mg/g gel tube Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane SubQ Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane Skinboosters Vital - Dermal tissue reconstructive material, microbe-derived Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane SubQ - Tissue reconstructive material, synthetic, fluid Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane Lyft - Dermal tissue reconstructive material, microbe-derived Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd
Galderma Australia Pty Ltd - Restylane - Tissue reconstructive material, synthetic, fluid Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Galderma Australia Pty Ltd

Pages

Current page 1
Page 2
Page 3
Page 4
Page 5
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.